Key result
Continuous monitoring of atrial fibrillation using implantable devices provides a more accurate assessment of AF burden than intermittent monitoring, which is crucial for guiding clinical decisions.
Continuous monitoring of atrial fibrillation provides a more accurate assessment of true arrhythmia burden compared to intermittent methods, directly impacting clinical decisions regarding anticoagulation, ablation efficacy, and device programming.
May refine AF monitoring in select patients; leaves open whether continuous assessment improves outcomes over intermittent strategies.
The monitoring of atrial fibrillation (AF) is performed using a variety of tools, ranging from the conventional Holter electrocardiogram to modern implantable loop recording with remote data exchange. The main clinical areas in AF where monitoring is crucial for decision-making are catheter and surgical ablation, as well as anticoagulation to prevent strokes. Identifying the patient cohort at risk - e.g., those with subclinical silent AF - is a challenge. In addition, the interaction of AF with implanted devices - e.g. AF-triggered inadequate shock therapy - should be the object of continuous monitoring. The prevention of inadequate shock delivery in particular is of major clinical importance.
No takes yet. Share an insight, caveat, or question.
Lewalter et al. (2012) conducted a review in Atrial fibrillation. Atrial fibrillation monitoring was evaluated. Continuous monitoring of atrial fibrillation using implantable devices provides a more accurate assessment of AF burden than intermittent monitoring, which is crucial for guiding clinical decisions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: